• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿素诱导的载脂蛋白血清淀粉样蛋白A变性揭示了六聚体的边缘稳定性。

Urea-induced denaturation of apolipoprotein serum amyloid A reveals marginal stability of hexamer.

作者信息

Wang Limin, Colón Wilfredo

机构信息

Rensselaer Polytechnic Institute, Department of Chemistry and Chemical Biology, Troy, NY 12180, USA.

出版信息

Protein Sci. 2005 Jul;14(7):1811-7. doi: 10.1110/ps.051387005. Epub 2005 Jun 3.

DOI:10.1110/ps.051387005
PMID:15937280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2253367/
Abstract

Serum Amyloid A (SAA) is an acute phase reactant protein that is predominantly found bound to high-density lipoprotein in plasma. Upon inflammation, the plasma concentration of SAA can increase dramatically, occasionally leading to the development of amyloid A (AA) amyloidosis, which involves the deposition of SAA amyloid fibrils in major organs. We previously found that the murine isoform SAA2.2 exists in aqueous solution as a hexamer containing a central channel. Here we show using various biophysical and biochemical techniques that the SAA2.2 hexamer can be totally dissociated into monomer by approximately 2 M urea, with the concerted loss of its alpha-helical structure. However, limited trypsin proteolysis experiments in urea showed a conserved digestion profile, suggesting the preservation of major backbone topological features in the urea-denatured state of SAA2.2. The marginal stability of hexameric SAA2.2 and the presence of residual structure in the denatured monomeric protein suggest that both forms may interconvert in vivo to exert different functions to meet the various needs during normal physiological conditions and in response to inflammatory stimuli.

摘要

血清淀粉样蛋白A(SAA)是一种急性期反应蛋白,主要以与血浆中高密度脂蛋白结合的形式存在。在炎症反应时,血浆中SAA的浓度会急剧升高,偶尔会导致淀粉样蛋白A(AA)淀粉样变性的发生,这涉及SAA淀粉样原纤维在主要器官中的沉积。我们之前发现,小鼠同种型SAA2.2在水溶液中以含有中央通道的六聚体形式存在。在此,我们使用各种生物物理和生化技术表明,SAA2.2六聚体可被约2 M尿素完全解离为单体,同时其α-螺旋结构协同丧失。然而,在尿素中进行的有限胰蛋白酶消化实验显示出保守的消化图谱,这表明在SAA2.2的尿素变性状态下,主要的主链拓扑特征得以保留。六聚体SAA2.2的边缘稳定性以及变性单体蛋白中残余结构的存在表明,这两种形式可能在体内相互转化,以发挥不同功能,满足正常生理条件下以及应对炎症刺激时的各种需求。

相似文献

1
Urea-induced denaturation of apolipoprotein serum amyloid A reveals marginal stability of hexamer.尿素诱导的载脂蛋白血清淀粉样蛋白A变性揭示了六聚体的边缘稳定性。
Protein Sci. 2005 Jul;14(7):1811-7. doi: 10.1110/ps.051387005. Epub 2005 Jun 3.
2
Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel.溶液中的小鼠载脂蛋白血清淀粉样蛋白A形成一种含有中央通道的六聚体。
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):15947-52. doi: 10.1073/pnas.252508399. Epub 2002 Nov 27.
3
From hexamer to amyloid: marginal stability of apolipoprotein SAA2.2 leads to in vitro fibril formation at physiological temperature.从六聚体到淀粉样蛋白:载脂蛋白SAA2.2的边缘稳定性导致其在生理温度下体外形成原纤维。
Amyloid. 2005 Sep;12(3):139-48. doi: 10.1080/13506120500223084.
4
Effect of zinc, copper, and calcium on the structure and stability of serum amyloid A.锌、铜和钙对血清淀粉样蛋白A结构和稳定性的影响。
Biochemistry. 2007 May 8;46(18):5562-9. doi: 10.1021/bi602629y. Epub 2007 Apr 11.
5
Serum amyloid A 2.2 refolds into a octameric oligomer that slowly converts to a more stable hexamer.血清淀粉样蛋白 A2.2 重新折叠成八聚体寡聚物,然后缓慢转化为更稳定的六聚体。
Biochem Biophys Res Commun. 2011 Apr 22;407(4):725-9. doi: 10.1016/j.bbrc.2011.03.090. Epub 2011 Mar 31.
6
The interaction between apolipoprotein serum amyloid A and high-density lipoprotein.载脂蛋白血清淀粉样蛋白A与高密度脂蛋白之间的相互作用。
Biochem Biophys Res Commun. 2004 Apr 23;317(1):157-61. doi: 10.1016/j.bbrc.2004.03.027.
7
Inflammation protein SAA2.2 spontaneously forms marginally stable amyloid fibrils at physiological temperature.炎症蛋白 SAA2.2 在生理温度下自发形成边缘稳定的淀粉样纤维。
Biochemistry. 2011 Nov 1;50(43):9184-91. doi: 10.1021/bi200856v. Epub 2011 Oct 5.
8
Intrinsic Stability, Oligomerization, and Amyloidogenicity of HDL-Free Serum Amyloid A.无高密度脂蛋白血清淀粉样蛋白A的内在稳定性、寡聚化及淀粉样变性
Adv Exp Med Biol. 2015;855:117-34. doi: 10.1007/978-3-319-17344-3_5.
9
Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2.致病血清淀粉样蛋白 A1.1 显示出长的富含寡聚体的纤维形成延滞期,与高度致淀粉样的非致病 SAA2.2 相反。
J Biol Chem. 2013 Jan 25;288(4):2744-55. doi: 10.1074/jbc.M112.394155. Epub 2012 Dec 5.
10
Influence of the carboxy terminus of serum amyloid A on protein oligomerization, misfolding, and fibril formation.血清淀粉样蛋白 A 羧基末端对蛋白寡聚化、错误折叠和纤维形成的影响。
Biochemistry. 2012 Apr 10;51(14):3092-9. doi: 10.1021/bi201903s. Epub 2012 Mar 26.

引用本文的文献

1
Diabetes mellitus drug discovery: insights into targeting feline and human amylin with small molecules.糖尿病药物发现:小分子靶向猫和人胰岛淀粉样肽的研究进展。
Vet Q. 2023 Dec;43(1):1-12. doi: 10.1080/01652176.2023.2260442. Epub 2023 Oct 4.
2
Interleukin-1β Induces Intracellular Serum Amyloid A1 Expression in Human Coronary Artery Endothelial Cells and Promotes its Intercellular Exchange.白细胞介素-1β诱导人冠状动脉内皮细胞内血清淀粉样蛋白 A1 的表达并促进其细胞间交换。
Inflammation. 2019 Aug;42(4):1413-1425. doi: 10.1007/s10753-019-01003-3.
3
Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A.糖胺聚糖对血清淀粉样蛋白A体外聚集的不同作用。
Biochimie. 2014 Sep;104:70-80. doi: 10.1016/j.biochi.2014.05.007. Epub 2014 May 28.
4
Characterization of the oligomerization and aggregation of human Serum Amyloid A.人血清淀粉样蛋白A的寡聚化和聚集特性
PLoS One. 2013 Jun 4;8(6):e64974. doi: 10.1371/journal.pone.0064974. Print 2013.
5
Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2.致病血清淀粉样蛋白 A1.1 显示出长的富含寡聚体的纤维形成延滞期,与高度致淀粉样的非致病 SAA2.2 相反。
J Biol Chem. 2013 Jan 25;288(4):2744-55. doi: 10.1074/jbc.M112.394155. Epub 2012 Dec 5.
6
Colocalization of serum amyloid a with microtubules in human coronary artery endothelial cells.血清淀粉样蛋白A与人冠状动脉内皮细胞中微管的共定位
J Biomed Biotechnol. 2011;2011:528276. doi: 10.1155/2011/528276. Epub 2011 Oct 27.
7
Serum amyloid A 2.2 refolds into a octameric oligomer that slowly converts to a more stable hexamer.血清淀粉样蛋白 A2.2 重新折叠成八聚体寡聚物,然后缓慢转化为更稳定的六聚体。
Biochem Biophys Res Commun. 2011 Apr 22;407(4):725-9. doi: 10.1016/j.bbrc.2011.03.090. Epub 2011 Mar 31.

本文引用的文献

1
From hexamer to amyloid: marginal stability of apolipoprotein SAA2.2 leads to in vitro fibril formation at physiological temperature.从六聚体到淀粉样蛋白:载脂蛋白SAA2.2的边缘稳定性导致其在生理温度下体外形成原纤维。
Amyloid. 2005 Sep;12(3):139-48. doi: 10.1080/13506120500223084.
2
Natively unfolded domains in endocytosis: hooks, lines and linkers.内吞作用中的天然未折叠结构域:钩子、绳索和连接子
EMBO Rep. 2004 Nov;5(11):1046-52. doi: 10.1038/sj.embor.7400276.
3
The interaction between apolipoprotein serum amyloid A and high-density lipoprotein.载脂蛋白血清淀粉样蛋白A与高密度脂蛋白之间的相互作用。
Biochem Biophys Res Commun. 2004 Apr 23;317(1):157-61. doi: 10.1016/j.bbrc.2004.03.027.
4
Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel.溶液中的小鼠载脂蛋白血清淀粉样蛋白A形成一种含有中央通道的六聚体。
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):15947-52. doi: 10.1073/pnas.252508399. Epub 2002 Nov 27.
5
Natively unfolded proteins: a point where biology waits for physics.天然未折叠蛋白:生物学等待物理学介入之处。
Protein Sci. 2002 Apr;11(4):739-56. doi: 10.1110/ps.4210102.
6
Inflammation and atherosclerosis.炎症与动脉粥样硬化。
Circulation. 2002 Mar 5;105(9):1135-43. doi: 10.1161/hc0902.104353.
7
Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease.血清淀粉样蛋白A及其他急性期蛋白对冠心病的鉴别价值。
Atherosclerosis. 2002 Feb;160(2):471-6. doi: 10.1016/s0021-9150(01)00607-4.
8
Markers of inflammation and coronary artery disease.炎症与冠状动脉疾病的标志物。
Med Sci Monit. 2002 Jan;8(1):RA5-12.
9
Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.与血清淀粉样蛋白A蛋白循环浓度相关的AA型淀粉样变性中的淀粉样蛋白负荷及临床结局
Lancet. 2001 Jul 7;358(9275):24-9. doi: 10.1016/S0140-6736(00)05252-1.
10
Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states.主要急性期蛋白血清淀粉样蛋白A在正常及疾病状态下的表达与功能
Curr Opin Hematol. 2000 Jan;7(1):64-9. doi: 10.1097/00062752-200001000-00012.